Acute myeloid leukemia (AML), the second most common leukemia in children, is hard to treat and has a five-year survival rate of just 65 to 70%, according to the American Cancer Society. While immunotherapies like monoclonal ...
Sep 30, 2023
0
21
Rabies virus is incurable and almost always fatal once it has invaded the central nervous system, with the victim doomed to suffer a horrible death.
Sep 28, 2023
0
2
Emory Vaccine Center researchers say they have identified the Achilles heel of SARS-CoV-2, the virus that causes COVID-19.
Sep 26, 2023
0
82
There has been an outbreak of the deadly Nipah virus in Kerala, India. Five people have caught the virus, two of whom have died.
Sep 20, 2023
0
2
Today, HIV can be managed with medical treatment. However, despite 40 years of intensive research, scientists have not yet succeeded in finding a cure for the disease. People with HIV experience a flare-up of the virus only ...
Sep 18, 2023
1
46
Cancer patients appeared to benefit from natural killer cells obtained from donors in an experimental method of treating cancer that involved an aggressive army of immune system fighters endowed with the ability to home in ...
An increase in the Southeast of respiratory syncytial virus, better known as RSV, may be an early sign of the start of the respiratory virus season.
Sep 7, 2023
0
2
In a paper, "Epitope editing enables targeted immunotherapy of acute myeloid leukaemia," published in Nature, researchers at the Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, introduce a genetic ...
A new article published in RadioGraphics examines the use of monoclonal antibody therapies for treating Alzheimer's disease and alerts physicians to be on the lookout for a potential side effect: amyloid-related imaging abnormalities ...
Aug 31, 2023
0
2
With the Food and Drug Administration's Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have a major new tool at its disposal to ...
Aug 28, 2023
0
6
Monoclonal antibodies (mAb or moAb) are monospecific antibodies that are identical because they are produced by one type of immune cell that are all clones of a single parent cell. Given almost any substance, it is possible to create monoclonal antibodies that specifically bind to that substance; they can then serve to detect or purify that substance. This has become an important tool in biochemistry, molecular biology and medicine. When used as medications, the generic drug name ends in -mab (see "Nomenclature of monoclonal antibodies").
This text uses material from Wikipedia, licensed under CC BY-SA
